CIZZLE BIOTECHNOLOGY HOLDINGS PLC
A cancer diagnostics developer creating a blood test for early lung cancer detection.
CIZ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNG2VN02
- LEI:
- 213800G3OS3SA2J1Y358
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
- Website:
- https://cizzlebiotechnology.com/
Description
Cizzle Biotechnology Holdings PLC is a cancer diagnostics developer focused on the early detection of lung cancer. The company is advancing a non-invasive, cost-effective blood test designed to identify lung cancer at its earliest stages, often before symptoms appear. The test utilizes a proprietary CIZ1B biomarker and an advanced immunoassay. Its primary goal is to improve patient outcomes by enabling swift, curative medical intervention. The technology aims to streamline the diagnostic pathway, reduce reliance on CT scans which can have high false-positive rates, and eliminate unnecessary invasive follow-up procedures. The company, a spin-out from the University of York, is conducting clinical trials to support global regulatory approval and adoption of its technology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-05 08:35 |
£250,000 Convertible Loan Note Issue
|
English | 16.3 KB | ||
| 2025-11-05 08:20 |
LOI with leading UK Clinical Diagnostic Group
|
English | 16.3 KB | ||
| 2025-09-29 08:00 |
Update on Clinical Laboratory Partnerships in USA
|
English | 22.2 KB | ||
| 2025-08-18 08:00 |
Commercial Progress in USA
|
English | 22.0 KB | ||
| 2025-07-08 10:40 |
Annual Report for the year ended 31 December 2024
|
English | 332.7 KB | ||
| 2025-06-06 12:00 |
Notice of AGM
|
English | 11.4 KB | ||
| 2025-05-28 08:00 |
Holding(s) in Company
|
English | 51.1 KB | ||
| 2025-03-25 08:00 |
Appointment of Non-Executive Director
|
English | 15.7 KB | ||
| 2025-01-02 08:00 |
Appointment of Professor Dawn Coverley as CSO
|
English | 17.8 KB | ||
| 2024-12-16 08:00 |
Update on Strategic Partnership in North America
|
English | 23.8 KB | ||
| 2024-10-21 08:00 |
Execution of Agreement for North America
|
English | 25.9 KB | ||
| 2024-10-03 14:12 |
Update on Licensing and Partnership Agreement
|
English | 10.6 KB | ||
| 2024-09-30 08:00 |
Interim Results
|
English | 208.3 KB | ||
| 2024-09-16 08:00 |
Holding(s) in Company
|
English | 37.5 KB | ||
| 2024-09-09 08:00 |
Collaboration with Moffitt Cancer Center
|
English | 25.0 KB |
Automate Your Workflow. Get a real-time feed of all CIZZLE BIOTECHNOLOGY HOLDINGS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CIZZLE BIOTECHNOLOGY HOLDINGS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CIZZLE BIOTECHNOLOGY HOLDINGS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
